MAPK3 and neoplasm: Metformin reduced tumor topoisomerase IIα, Ki-67, phospho-rpS6, and phospho-ERK1/2 and increased tumor phospho-AMPKMetformin decreased serum insulin, glucose, and IGF-1metformin decreased ability of sera to stimulate DNA synthesis in cultured cells